AEON Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
AEON Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2023 to Q2 2024.
  • AEON Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $1.58M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.58M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $213K Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $292K Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 $370K Sep 30, 2023 10-Q/A 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.